TSU
PFE icon

TD Securities (USA)’s Pfizer PFE Stock Holding History

TD Securities (USA)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$40K Sell
1,440
-22
-2% -$628 0.37% 20
2015
Q4 		$45K Sell
1,462
-2,253
-61% -$70.9K 0.41% 17
2015
Q3 		$111K Sell
3,715
-2,624,780
-100% -$84.2M 1.02% 16
2015
Q2 		$83.6M Buy
2,628,495
+307,885
+13% +$10M 1.13% 11
2015
Q1 		$76.6M Sell
2,320,610
-201,159
-8% -$6.4M 1.15% 11
2014
Q4 		$74.5M Buy
2,521,769
+184,033
+8% +$5.28M 1.07% 12
2014
Q3 		$65.6M Sell
2,337,736
-12,553
-0.5% -$352K 1.06% 13
2014
Q2 		$66.2M Buy
2,350,289
+142,560
+6% +$4.06M 1.06% 13
2014
Q1 		$67.3M Sell
2,207,729
-202,351
-8% -$6.03M 1.2% 12
2013
Q4 		$70M Buy
2,410,080
+20,981
+0.9% +$611K 1.18% 12
2013
Q3 		$65.1M Sell
2,389,099
-9,153
-0.4% -$249K 1.24% 13
2013
Q2 		$63.7M Buy
+2,398,252
New +$66.3M 1.27% 14

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

TD Securities (USA)'s PFE Position: Q1 2016 in Review

TD Securities (USA) reduced its Pfizer (PFE) stake by 1.5% in Q1 2016, selling an estimated $628 and leaving 1,440 shares worth $40K. The position accounts for 0.37% of the portfolio, ranked #20.

TD Securities (USA) first reported a position in PFE in Q2 2013 and has held it in 12 quarters since. The position peaked at $83.6M in Q2 2015. 1,968 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

  • TD Securities (USA) held 1,440 shares of Pfizer worth $40K as of Q1 2016.
  • TD Securities (USA) sold 22 Pfizer shares in Q1 2016, an estimated $628.
  • Pfizer made up 0.37% of TD Securities (USA)'s portfolio in Q1 2016, its #20 holding.
  • TD Securities (USA) first reported a position in Pfizer in Q2 2013 and has held it in 12 quarters since.
  • TD Securities (USA)'s Pfizer position peaked at $83.6M in Q2 2015.
  • 1,968 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.